Jim Sullivan

Jim Sullivan has a diverse work experience in the biotechnology and pharmaceutical industry. Jim is currently serving as the Chief Scientific Officer at enGene since February 2022. Prior to this, they held the position of Senior Vice President, Pulmonary Discovery at Translate Bio from January 2021 to January 2022. From August 2019 to January 2021, they worked as the Executive Director and Head of Translational Biology at Sana Biotechnology, Inc. Jim also has a long history with Vertex Pharmaceuticals, where they served as a Director from January 2008 to August 2019. Jim began their career as a Scientist at Bristol-Myers Squibb from an unknown start date to 2005.

Jim Sullivan has a Doctor of Philosophy (Ph.D.) in Genome Sciences/Genetics from Boston University, a Master's degree in Environmental Chemistry from University College Dublin, and a Bachelor's Degree in Biology from Boston College.